The Therapeutic Approach and Mechanism of Action of Insulin Eye Drops for the Treatment of Neurotrophic Keratitis

Read full text Summarise with VIRAT
Authors: Isabel Stasik, Eleftherios Chatzimichail, Efstratia Amaxilati, P. Konstas, Nicolas Feltgen, Georgios D. Panos, Zisis Gatzioufas
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neurotrophic keratopathy or keratitis (NK) is a degenerative corneal disorder characterised by reduced corneal sensitivity and impaired epithelial repair, most often associated with trigeminal nerve dysfunction. Topical insulin eye drops have been proposed as a potential adjunctive therapy, but wider clinical adoption is constrained by variability in preparation methods, inconsistent dosing approaches, and the absence of consensus guidance or regulatory approval. Current clinical experience suggests that topical insulin may be well tolerated and could offer therapeutic value in selected NK settings, including difficult-to-manage cases. Nonetheless, the overall evidence base remains limited and heterogeneous, making it challenging to define optimal regimens or confidently position topical insulin within existing treatment pathways. This review includes clinical studies and case reports and highlights the role of TI as a promising, cost-effective and well-tolerated treatment option for neurotrophic keratopathy, especially in refractory cases. This work also illustrates the need for further research to standardise formulation and dosing, establish practical clinical guidance, and clarify the patient populations and disease stages most likely to benefit, as well as the role of topical insulin alongside established interventions.

Fields of Study & Subjects

Ocular Surface and Contact Lens Corneal Surgery and Treatments Ocular Infections and Treatments

Publication details

Journal / source
Drug Design Development and Therapy
Volume
Volume 20
Pages
1–14
Publication date
1 March 2026
Language
EN